(DMAC) Diamedica Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Diamedica Therapeutics | (DMAC) share price targets
Complete technical analysis of Diamedica Therapeutics (DMAC) by charts plus indicators, forecast predictions and share price targets for Diamedica Therapeutics (DMAC)
Diamedica Therapeutics trades in USA in Health Care sector.
Showing technical analysis as on 2024-07-10 View latest technical analysis
10 day averaged volume of Diamedica Therapeutics is 193670
| Date | Daily Closing Price | Open | High | Low | Volume |
| 10 Wed Jul 2024 | 3.00 | 3.03 | 3.07 | 2.98 | 0.194 times |
| 09 Tue Jul 2024 | 3.03 | 3.11 | 3.16 | 2.98 | 0.181 times |
| 08 Mon Jul 2024 | 3.09 | 2.90 | 3.19 | 2.90 | 0.58 times |
| 05 Fri Jul 2024 | 2.90 | 2.90 | 2.94 | 2.83 | 0.18 times |
| 03 Wed Jul 2024 | 2.89 | 2.81 | 2.95 | 2.80 | 0.199 times |
| 03 Wed Jul 2024 | 2.89 | 2.81 | 2.95 | 2.80 | 0.199 times |
| 02 Tue Jul 2024 | 2.80 | 3.08 | 3.08 | 2.72 | 0.73 times |
| 01 Mon Jul 2024 | 2.95 | 2.95 | 2.95 | 2.65 | 1.238 times |
| 28 Fri Jun 2024 | 2.95 | 3.09 | 3.09 | 2.88 | 0.203 times |
| 27 Thu Jun 2024 | 3.05 | 2.99 | 3.05 | 2.74 | 0.401 times |
Share price targets for Diamedica Therapeutics (DMAC)
| Target Type | Value |
| Downside Target | 2.14 |
| Downside Target | 2.26 |
| Downside Target | 2.44 |
| Downside Target | 2.50 |
| Downside Target | 2.65 |
| Downside Target | 2.80 |
| Downside Target | 2.90 |
| Upside Target | 3.08 |
| Upside Target | 3.19 |
| Upside Target | 3.20 |
| Upside Target | 3.24 |
| Upside Target | 3.34 |
| Upside Target | 3.73 |
Intraday share price targets for Diamedica Therapeutics (DMAC)
| Target Type | Value |
| Downside Intraday Target | 2.87 |
| Downside Intraday Target | 2.74 |
| Upside Intraday Target | 3.16 |
| Upside Intraday Target | 3.32 |
| Upside Intraday Target | 3.03 |
Weekly technical analysis of Diamedica Therapeutics (DMAC)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 10 Wed Jul 2024 | 3.00 | 2.90 | 3.19 | 2.90 | 2.519 times |
| 05 Fri Jul 2024 | 2.90 | 2.81 | 2.95 | 2.80 | 0.175 times |
| 03 Wed Jul 2024 | 2.89 | 2.95 | 3.08 | 2.65 | 0.311 times |
| 28 Fri Jun 2024 | 2.95 | 2.14 | 3.24 | 2.14 | 14.132 times |
| 21 Fri Jun 2024 | 2.16 | 2.36 | 2.44 | 2.16 | 1.967 times |
Price has moved up this week, and volume has increased substantially. This means that the move can continue in coming weeks.
Monthly technical analysis of Diamedica Therapeutics (DMAC)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 10 Wed Jul 2024 | 3.00 | 2.95 | 3.19 | 2.65 | 0.39 times |
| 28 Fri Jun 2024 | 2.95 | 2.93 | 3.24 | 2.14 | 2.027 times |
| 31 Fri May 2024 | 2.90 | 2.58 | 3.73 | 2.50 | 1.157 times |
| 30 Tue Apr 2024 | 2.53 | 2.74 | 3.20 | 2.26 | 0.867 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Diamedica Therapeutics (DMAC)
Price action analysis of Diamedica Therapeutics ( (DMAC) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Diamedica Therapeutics ( (DMAC) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Diamedica Therapeutics ( (DMAC) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Diamedica Therapeutics ( (DMAC) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Diamedica Therapeutics stock for short term is BUY. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Diamedica Therapeutics in short term and the buy signal is strong.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Diamedica Therapeutics Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Diamedica Therapeutics in short term but SELL signal is weak.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Diamedica Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 2.95 and Diamedica Therapeutics (DMAC) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Diamedica Therapeutics (DMAC) stock. Volume based technical analysis of Diamedica Therapeutics (DMAC) stock is negative.
Diamedica Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Diamedica Therapeutics ( (DMAC) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Diamedica Therapeutics ( (DMAC) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Diamedica Therapeutics ( (DMAC) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Diamedica Therapeutics ( (DMAC) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Diamedica Therapeutics stock for short term is BUY. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Diamedica Therapeutics in short term and the buy signal is strong.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Diamedica Therapeutics Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Diamedica Therapeutics in short term but SELL signal is weak.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Diamedica Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 2.95 and Diamedica Therapeutics (DMAC) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Diamedica Therapeutics (DMAC) stock. Volume based technical analysis of Diamedica Therapeutics (DMAC) stock is negative.
Diamedica Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.